Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome

American Journal of Emergency Medicine

Volumn 28, Issue 2, 2010, Pages 170-176

  Hjortshøj, Søren ^a   Kristensen, Søren Risom ^a   Ravkilde, Jan ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE MB; ENOXAPARIN; FATTY ACID BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISCHEMIA MODIFIED ALBUMIN; LOW MOLECULAR WEIGHT HEPARIN; MYOGLOBIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY MONITORING; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; THORAX PAIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEST PAIN; DENMARK; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; ROC CURVE; SERUM ALBUMIN;

EID: 76249131502     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.10.038     Document Type: Article

References (25)

1. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 116 22 (2007) 2634-2653
2. Ravkilde J. Risk stratification in acute coronary syndrome using cardiac troponin I. Clin Chem 46 4 (2000) 443-444
3. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., and Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation During Instability in Coronary Artery Disease. Lancet 356 9223 (2000) 9-16
4. Bar-Or D., Curtis G., Rao N., Bampos N., and Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 268 1 (2001) 42-47
5. Bar-Or D., Rael L.T., Bar-Or R., et al. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387 1-2 (2008) 120-127
6. Abadie J.M., Blassingame C.L., and Bankson D.D. Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 35 1 (2005) 66-72
7. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19 4 (2000) 311-315
8. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 3 (2001) 464-470
9. Collinson P.O., Gaze D.C., Bainbridge K., et al. Utility of admission cardiac troponin and "ischemia modified albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 23 4 (2006) 256-261
10. Roy D., Quiles J., Aldama G., et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97 2 (2004) 297-301
11. Sinha M.K., Roy D., Gaze D.C., Collinson P.O., and Kaski J.C. Role of "ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21 1 (2004) 29-34
12. Wu A.H., Morris D.L., Fletcher D.R., Apple F.S., Christenson R.H., and Painter P.C. Analysis of the albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 1 2 (2001) 147-151
13. Peacock F., Morris D.L., Anwaruddin S., et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152 2 (2006) 253-262
14. Keating L., Benger J.R., Beetham R., et al. The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 23 10 (2006) 764-768
15. Can M., Demirtas S., Polat O., and Yildiz A. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J 23 7 (2006) 537-539
16. Falkensammer J., Stojakovic T., Huber K., et al. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. Clin Chem Lab Med 45 4 (2007) 535-540
17. Roy D., Quiles J., Sharma R., et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 50 9 (2004) 1656-1660
18. Roy D., Quiles J., Sinha M., et al. Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol 94 2 (2004) 234-236
19. Roy D., Quiles J., Sinha M., Aldama G., Gaze D., and Kaski J.C. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 93 3 (2004) 366-368
20. Borderie D., Allanore Y., Meune C., Devaux J.Y., Ekindjian O.G., and Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50 11 (2004) 2190-2193
21. Roche Diagnostics. Troponin T STAT (Short Turn Around Time), CARDIAC T 04660307 190 2007-07. 2007.
22. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., and Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 49 8 (2003) 1331-1336
23. Pelsers M.M., Chapelle J.P., Knapen M., et al. Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 45 3 (1999) 441-443
24. Lippi G., Montagnana M., Salvagno G.L., and Guidi G.C. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 45 2 (2007) 261-262
25. Worster A., Devereaux P.J., Heels-Ansdell D., et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172 13 (2005) 1685-1690